These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 526933

  • 1. Neurologic and cardiac rhythm abnormalities associated with 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) therapy.
    Legha SS, Latreille J, McCredie KB, Bodey GP.
    Cancer Treat Rep; 1979; 63(11-12):2001-3. PubMed ID: 526933
    [No Abstract] [Full Text] [Related]

  • 2. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in metastatic breast cancer.
    Legha SS, Blumenschein GR, Buzdar AU, Hortobagyi GN, Bodey GP.
    Cancer Treat Rep; 1979; 63(11-12):1961-4. PubMed ID: 526929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Phase II clinical evaluation of intravenous 4'-(9-acridinylamino)methanesulfon-m-anisidide in colorectal cancer.
    Valdivieso M, Stroehlein JR, Bedikian AY, Karlin DA, Legha SS, Bennetts RW, Bodey GP.
    Am J Clin Oncol; 1983 Feb; 6(1):39-44. PubMed ID: 6687657
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer.
    Currie VE, Howard J, Wittes R.
    Cancer Clin Trials; 1981 Feb; 4(3):249-51. PubMed ID: 6895189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
    Sordillo PP, Magill GB, Gralla RJ, Golbey RB.
    Cancer Treat Rep; 1980 Feb; 64(10-11):1129-30. PubMed ID: 6893950
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I-II study of m-AMSA administered as a continuous infusion.
    Micetich KC, Zwelling LA, Gormley P, Young RC.
    Cancer Treat Rep; 1982 Oct; 66(10):1813-7. PubMed ID: 6897013
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
    Van Echo DA, Markus S, Aisner J, Wiernik PH.
    Cancer Treat Rep; 1980 Oct; 64(8-9):1009-10. PubMed ID: 6893810
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
    Abate G, Villari P, Comella P, D'Aprile M, Castello G, Silvestro P, Zarrilli D, Pergola M.
    Haematologica; 1985 Oct; 70(1):35-8. PubMed ID: 3924754
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.